Number of Doses and Time to Onset Of Pain Relief (Analgesic Effect) Using the IONSYS System [Fentanyl Iontophoretic Transdermal System (40 microg)].
Phase of Trial: Phase III
Latest Information Update: 12 Aug 2016
At a glance
- Drugs Fentanyl (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 12 Aug 2016 Status changed from completed to discontinued.
- 25 Sep 2015 According to The Medicines Company media release, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending marketing authorization for IONSYS for treatment of poost-operative pain in adult patients.
- 30 Apr 2015 According to The Medicines Company media release, company has received USFDA approval for IONSYS.